Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002;90:251-262

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galis, Z. S.
Right arrow Articles by Khatri, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galis, Z. S.
Right arrow Articles by Khatri, J. J.
Related Collections
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Other Vascular biology
Right arrow Pathophysiology
(Circulation Research. 2002;90:251.)
© 2002 American Heart Association, Inc.


Review

Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis

The Good, the Bad, and the Ugly

Zorina S. Galis, Jaikirshan J. Khatri

From the Division of Cardiology, Departments of Medicine (Z.S.G., J.J.K.) and Biomedical Engineering (Z.S.G.), Emory University School of Medicine, Atlanta, Ga.

Correspondence to Zorina S. Galis, PhD, 1639 Pierce Dr, WMB 319, Atlanta, GA 30322. E-mail zgalis{at}emory.edu

Vascular remodeling, defined as any enduring change in the size and/or composition of an adult blood vessel, allows adaptation and repair. On the other hand, inappropriate remodeling, including its absence, underlies the pathogenesis of major cardiovascular diseases, such as atherosclerosis and restenosis. Since degradation of the extracellular matrix scaffold enables reshaping of tissue, participation of specialized enzymes called matrix metalloproteinases (MMPs) has become the object of intense recent interest in relation to physiological ("good") and pathological ("bad") vascular remodeling. Experimental evidence acquired in vitro and in vivo suggests that the major drivers of vascular remodeling, hemodynamics, injury, inflammation, and oxidative stress, regulate MMP expression and activity. Alternatively, nonspecific MMP inhibition seems to oppose remodeling, as suggested by the inhibition of intimal thickening and outward arterial remodeling. An emerging concept is that MMP-related genetic variations may contribute to heterogeneity in the presentation and natural history of atherosclerosis. The hypothesis that MMPs contribute to weakening of atherosclerotic plaques is especially attractive for the potential development of therapeutic interventions aimed at preventing plaque disruption ("the ugly"), a major cause of acute cardiovascular events. However, the current lack of appropriate experimental tools, including availability of specific MMP inhibitors and pertinent animal models, still limits our understanding of the many actions and relative contributions of specific MMPs. Our future potential ability to control vascular remodeling via regulation of MMPs will also depend on reaching a consensus of what is indeed "good" or "bad" vascular remodeling, concepts that have continued to evolve and change.


Key Words: atherosclerosis • extracellular matrix • metalloproteinases • arterial remodeling




This article has been cited by other articles:


Home page
QJMHome page
P. Welsh, P.H. Whincup, O. Papacosta, S.G. Wannamethee, L. Lennon, A. Thomson, A. Rumley, and G.D.O. Lowe
Serum matrix metalloproteinase-9 and coronary heart disease: a prospective study in middle-aged men
QJM, August 1, 2008; (2008) hcn088v1.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. W. Lee, N. J. Kang, M.-H. Oak, M. K. Hwang, J. H. Kim, V. B. Schini-Kerth, and H. J. Lee
Cocoa procyanidins inhibit expression and activation of MMP-2 in vascular smooth muscle cells by direct inhibition of MEK and MT1-MMP activities
Cardiovasc Res, July 1, 2008; 79(1): 34 - 41.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
C.-H. Pan, C.-H. Wen, and C.-S. Lin
Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes
Exp Physiol, May 1, 2008; 93(5): 599 - 612.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Delbosc, M. Glorian, A.-S. Le Port, G. Bereziat, M. Andreani, and I. Limon
The Benefit of Docosahexanoic Acid on the Migration of Vascular Smooth Muscle Cells Is Partially Dependent on Notch Regulation of MMP-2/-9
Am. J. Pathol., May 1, 2008; 172(5): 1430 - 1440.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Spinetti, N. Kraenkel, C. Emanueli, and P. Madeddu
Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies
Cardiovasc Res, May 1, 2008; 78(2): 265 - 273.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. N.T.P. Bakker, H. L. Matlung, P. Bonta, C. J. de Vries, N. van Rooijen, and E. VanBavel
Blood flow-dependent arterial remodelling is facilitated by inflammation but directed by vascular tone
Cardiovasc Res, May 1, 2008; 78(2): 341 - 348.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. H. Goldbarg, S. Elmariah, M. A. Miller, and V. Fuster
Reply
J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1416 - 1416.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Mannello
Serum or Plasma Samples?: The "Cinderella" Role of Blood Collection Procedures Preanalytical Methodological Issues Influence the Release and Activity of Circulating Matrix Metalloproteinases and Their Tissue Inhibitors, Hampering Diagnostic Trueness and Leading to Misinterpretation
Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 611 - 614.
[Full Text] [PDF]


Home page
PhlebologyHome page
J D Raffetto and R A Khalil
Mechanisms of varicose vein formation: valve dysfunction and wall dilation
Phlebology, April 1, 2008; 23(2): 85 - 98.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Zernecke, J. Bernhagen, and C. Weber
Macrophage Migration Inhibitory Factor in Cardiovascular Disease
Circulation, March 25, 2008; 117(12): 1594 - 1602.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Lancelot, V. Amirbekian, I. Brigger, J.-S. Raynaud, S. Ballet, C. David, O. Rousseaux, S. Le Greneur, M. Port, H. R. Lijnen, et al.
Evaluation of Matrix Metalloproteinases in Atherosclerosis Using a Novel Noninvasive Imaging Approach
Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 425 - 432.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
E. Wilton, M. Bland, M. Thompson, and M. Jahangiri
Matrix metalloproteinase expression in the ascending aorta and aortic valve
Interactive CardioVascular and Thoracic Surgery, February 1, 2008; 7(1): 37 - 40.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Zernecke, I. Bot, Y. Djalali-Talab, E. Shagdarsuren, K. Bidzhekov, S. Meiler, R. Krohn, A. Schober, M. Sperandio, O. Soehnlein, et al.
Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in Atherosclerosis
Circ. Res., February 1, 2008; 102(2): 209 - 217.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Fukuda, M. Sata, N. Ishizaka, and R. Nagai
Critical Role of Bone Marrow Angiotensin II Type 1 Receptor in the Pathogenesis of Atherosclerosis in Apolipoprotein E Deficient Mice
Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 90 - 96.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. T.Y. Li, K. E. Swales, G. J. Thomas, T. D. Warner, and D. Bishop-Bailey
Farnesoid X Receptor Ligands Inhibit Vascular Smooth Muscle Cell Inflammation and Migration
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2606 - 2611.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Hlawaty, A. San Juan, M.-P. Jacob, R. Vranckx, D. Letourneur, and L. J. Feldman
Inhibition of MMP-2 gene expression with small interfering RNA in rabbit vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3593 - H3601.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Baranek, R. Debret, F. Antonicelli, B. Lamkhioued, A. Belaaouaj, W. Hornebeck, P. Bernard, M. Guenounou, and R. Le Naour
Elastin Receptor (Spliced Galactosidase) Occupancy by Elastin Peptides Counteracts Proinflammatory Cytokine Expression in Lipopolysaccharide-Stimulated Human Monocytes through NF-{kappa}B Down-Regulation
J. Immunol., November 1, 2007; 179(9): 6184 - 6192.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Armstrong, S. Abilleira, M. Sitzer, H. S. Markus, and S. Bevan
Polymorphisms in MMP Family and TIMP Genes and Carotid Artery Intima-Media Thickness
Stroke, November 1, 2007; 38(11): 2895 - 2899.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Niessner, M. S. Shin, O. Pryshchep, J. J. Goronzy, E. L. Chaikof, and C. M. Weyand
Synergistic Proinflammatory Effects of the Antiviral Cytokine Interferon-{alpha} and Toll-Like Receptor 4 Ligands in the Atherosclerotic Plaque
Circulation, October 30, 2007; 116(18): 2043 - 2052.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. H. Goldbarg, S. Elmariah, M. A. Miller, and V. Fuster
Insights Into Degenerative Aortic Valve Disease
J. Am. Coll. Cardiol., September 25, 2007; 50(13): 1205 - 1213.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Gogly, A. Naveau, B. Fournier, N. Reinald, E. Durand, C. Brasselet, B. Coulomb, and A. Lafont
Preservation of Rabbit Aorta Elastin From Degradation by Gingival Fibroblasts in an Ex Vivo Model
Arterioscler. Thromb. Vasc. Biol., September 1, 2007; 27(9): 1984 - 1990.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Koide, P. L. Penar, B. I. Tranmer, and G. C. Wellman
Heparin-binding EGF-like growth factor mediates oxyhemoglobin-induced suppression of voltage-dependent potassium channels in rabbit cerebral artery myocytes
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1750 - H1759.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. C.M. Siow and A. T. Churchman
Adventitial growth factor signalling and vascular remodelling: Potential of perivascular gene transfer from the outside-in
Cardiovasc Res, September 1, 2007; 75(4): 659 - 668.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. J. White, S. J. Duffy, A. S. Walton, J. F. Ng, G. E. Rice, S. Mukherjee, J. A. Shaw, G. L. Jennings, A. M. Dart, and B. A. Kingwell
Matrix metalloproteinase-3 and coronary remodelling: Implications for unstable coronary disease
Cardiovasc Res, September 1, 2007; 75(4): 813 - 820.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Aoki, H. Kataoka, T. Moriwaki, K. Nozaki, and N. Hashimoto
Role of TIMP-1 and TIMP-2 in the Progression of Cerebral Aneurysms
Stroke, August 1, 2007; 38(8): 2337 - 2345.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. S. Chatzizisis, A. U. Coskun, M. Jonas, E. R. Edelman, C. L. Feldman, and P. H. Stone
Role of Endothelial Shear Stress in the Natural History of Coronary Atherosclerosis and Vascular Remodeling: Molecular, Cellular, and Vascular Behavior
J. Am. Coll. Cardiol., June 26, 2007; 49(25): 2379 - 2393.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. J. Wu, N. Di Girolamo, K. Beck, C. G. Hanratty, K. Choy, J. Y. Hou, M. R. Ward, and R. Stocker
Probucol [4,4'-[(1-Methylethylidene)bis(thio)]bis-[2,6-bis(1,1-dimethylethyl)phenol]] Inhibits Compensatory Remodeling and Promotes Lumen Loss Associated with Atherosclerosis in Apolipoprotein E-Deficient Mice
J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 477 - 484.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. D. Overton, P. G. Yancey, A. S. Major, M. F. Linton, and S. Fazio
Deletion of Macrophage LDL Receptor-Related Protein Increases Atherogenesis in the Mouse
Circ. Res., March 16, 2007; 100(5): 670 - 677.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Zalba, A. Fortuno, J. Orbe, G. San Jose, M. U. Moreno, M. Belzunce, J. A. Rodriguez, O. Beloqui, J. A. Paramo, and J. Diez
Phagocytic NADPH Oxidase-Dependent Superoxide Production Stimulates Matrix Metalloproteinase-9: Implications for Human Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 587 - 593.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Segers, F. Helderman, C. Cheng, L. C.A. van Damme, D. Tempel, E. Boersma, P. W. Serruys, R. de Crom, A. F.W. van der Steen, P. Holvoet, et al.
Gelatinolytic Activity in Atherosclerotic Plaques Is Highly Localized and Is Associated With Both Macrophages and Smooth Muscle Cells In Vivo
Circulation, February 6, 2007; 115(5): 609 - 616.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
Y.-W. Wu, H.-L. Kao, M.-F. Chen, B.-C. Lee, W.-Y. I. Tseng, J.-S. Jeng, K.-Y. Tzen, R.-F. Yen, P.-J. Huang, and W.-S. Yang
Characterization of Plaques Using 18F-FDG PET/CT in Patients with Carotid Atherosclerosis and Correlation with Matrix Metalloproteinase-1
J. Nucl. Med., February 1, 2007; 48(2): 227 - 233.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. Saloner, G. Acevedo-Bolton, M. Wintermark, and J. H. Rapp
MRI of Geometric and Compositional Features of Vulnerable Carotid Plaque
Stroke, February 1, 2007; 38(2): 637 - 641.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. K. Lund, T. L. Knuckles, C. Obot Akata, R. Shohet, J. D. McDonald, A. Gigliotti, J. C. Seagrave, and M. J. Campen
Gasoline Exhaust Emissions Induce Vascular Remodeling Pathways Involved in Atherosclerosis
Toxicol. Sci., February 1, 2007; 95(2): 485 - 494.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Fulop, R. B. Marchase, and J. C. Chatham
Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system
Cardiovasc Res, January 15, 2007; 73(2): 288 - 297.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. D. Schmoker, K. J. McPartland, E. K. Fellinger, J. Boyum, L. Trombley, F. P. Ittleman, C. Terrien III, A. Stanley, and A. Howard
Matrix metalloproteinase and tissue inhibitor expression in atherosclerotic and nonatherosclerotic thoracic aortic aneurysms
J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 155 - 161.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Koenig and N. Khuseyinova
Biomarkers of Atherosclerotic Plaque Instability and Rupture
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 15 - 26.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
S. Abilleira, S. Bevan, and H. S Markus
The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis
J. Med. Genet., December 1, 2006; 43(12): 897 - 901.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Cuenca, P. Martin-Sanz, A. M. Alvarez-Barrientos, L. Bosca, and N. Goren
Infiltration of Inflammatory Cells Plays an Important Role in Matrix Metalloproteinase Expression and Activation in the Heart during Sepsis
Am. J. Pathol., November 1, 2006; 169(5): 1567 - 1576.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Eldrup, M.-L. M. Gronholdt, H. Sillesen, and B. G. Nordestgaard
Elevated Matrix Metalloproteinase-9 Associated With Stroke or Cardiovascular Death in Patients With Carotid Stenosis
Circulation, October 24, 2006; 114(17): 1847 - 1854.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Secchiero, R. Candido, F. Corallini, S. Zacchigna, B. Toffoli, E. Rimondi, B. Fabris, M. Giacca, and G. Zauli
Systemic Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Delivery Shows Antiatherosclerotic Activity in Apolipoprotein E-Null Diabetic Mice
Circulation, October 3, 2006; 114(14): 1522 - 1530.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
K De Leeuw, B Freire, A J Smit, H Bootsma, C G Kallenberg, and M Bijl
Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus
Lupus, October 1, 2006; 15(10): 675 - 682.
[Abstract] [PDF]


Home page
Hum ReprodHome page
S. Malik, K. Day, I. Perrault, D.S. Charnock-Jones, and S. K. Smith
Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-{alpha} in menstrual endometrium and effluent in women with menorrhagia
Hum. Reprod., August 1, 2006; 21(8): 2158 - 2166.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. M. Mallawaarachchi, P. L. Weissberg, and R. C. M. Siow
Antagonism of platelet-derived growth factor by perivascular gene transfer attenuates adventitial cell migration after vascular injury: new tricks for old dogs?
FASEB J, August 1, 2006; 20(10): 1686 - 1688.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
L. Nilsson, L. Jonasson, J. Nijm, A. Hamsten, and P. Eriksson
Increased Plasma Concentration of Matrix Metalloproteinase-7 in Patients with Coronary Artery Disease
Clin. Chem., August 1, 2006; 52(8): 1522 - 1527.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X. Qin, M. A. Corriere, L. M. Matrisian, and R. J. Guzman
Matrix Metalloproteinase Inhibition Attenuates Aortic Calcification
Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1510 - 1516.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C.-F. Lai, V. Seshadri, K. Huang, J.-S. Shao, J. Cai, R. Vattikuti, A. Schumacher, A. P. Loewy, D. T. Denhardt, S. R. Rittling, et al.
An Osteopontin-NADPH Oxidase Signaling Cascade Promotes Pro-Matrix Metalloproteinase 9 Activation in Aortic Mesenchymal Cells
Circ. Res., June 23, 2006; 98(12): 1479 - 1489.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. von Wnuck Lipinski, P. Keul, N. Ferri, S. Lucke, G. Heusch, J. W. Fischer, and B. Levkau
Integrin-Mediated Transcriptional Activation of Inhibitor of Apoptosis Proteins Protects Smooth Muscle Cells Against Apoptosis Induced by Degraded Collagen
Circ. Res., June 23, 2006; 98(12): 1490 - 1497.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Chandrasekar, S. Mummidi, L. Mahimainathan, D. N. Patel, S. R. Bailey, S. Z. Imam, W. C. Greene, and A. J. Valente
Interleukin-18-induced Human Coronary Artery Smooth Muscle Cell Migration Is Dependent on NF-{kappa}B- and AP-1-mediated Matrix Metalloproteinase-9 Expression and Is Inhibited by Atorvastatin
J. Biol. Chem., June 2, 2006; 281(22): 15099 - 15109.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Fiotti, N. Altamura, M. Fisicaro, N. Carraro, L. Uxa, G. Grassi, L. Torelli, R. Gobbato, G. Guarnieri, B. T. Baxter, et al.
MMP-9 Microsatellite Polymorphism and Susceptibility to Carotid Arteries Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1330 - 1336.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A.P.J.J. Bijnens, E. Lutgens, T. Ayoubi, J. Kuiper, A.J. Horrevoets, and M.J.A.P. Daemen
Genome-Wide Expression Studies of Atherosclerosis: Critical Issues in Methodology, Analysis, Interpretation of Transcriptomics Data
Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1226 - 1235.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Bujo and Y. Saito
Modulation of Smooth Muscle Cell Migration by Members of the Low-Density Lipoprotein Receptor Family
Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1246 - 1252.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. L. Martin-Ventura, V. Nicolas, X. Houard, L. M. Blanco-Colio, A. Leclercq, J. Egido, R. Vranckx, J.-B. Michel, and O. Meilhac
Biological Significance of Decreased HSP27 in Human Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1337 - 1343.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Zernecke, E. A. Liehn, J.-L. Gao, W. A. Kuziel, P. M. Murphy, and C. Weber
Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10
Blood, June 1, 2006; 107(11): 4240 - 4243.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
L. Chen, X. Wang, S. A. Carter, Y. H. Shen, H. R. Bartsch, R. W. Thompson, J. S. Coselli, D. L. Wilcken, X. L. Wang, and S. A. LeMaire
A single nucleotide polymorphism in the matrix metalloproteinase 9 gene (-8202A/G) is associated with thoracic aortic aneurysms and thoracic aortic dissection
J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1045 - 1052.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Kuzuya, K. Nakamura, T. Sasaki, X. Wu Cheng, S. Itohara, and A. Iguchi
Effect of MMP-2 Deficiency on Atherosclerotic Lesion Formation in ApoE-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1120 - 1125.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. P. Robinson III, C. D. Douillet, P. M. Milano, R. C. Boucher, C. Patterson, and P. B. Rich
ATP stimulates MMP-2 release from human aortic smooth muscle cells via JNK signaling pathway
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1988 - H1996.
[Abstract] [Full Text] [PDF]